Protherics PLC (“Protherics” or the " Company”), the biopharmaceutical company focused on critical care and oncology, today provides a pre-close trading update in advance of its preliminary results for the period ended 31 March 2006.
Protherics PLC (“Protherics” or the " Company”), the biopharmaceutical company focused on critical care and oncology, today provides a pre-close trading update in advance of its preliminary results for the period ended 31 March 2006.
